The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis.
hernandez_jca@gva.es.
Juan-Carlos
JC
Hernández-Boluda
Arturo
A
Pereira
Montse
M
Gómez
Concepción
C
Boqué
Francisca
F
Ferrer-Marín
José-María
JM
Raya
Valentín
V
García-Gutiérrez
Ana
A
Kerguelen
Blanca
B
Xicoy
Pere
P
Barba
Jesús
J
Martínez
Elisa
E
Luño
Alberto
A
Alvarez-Larrán
Joaquín
J
Martínez-López
Elisa
E
Arbelo
Carles
C
Besses
D006801:Humans; D011087:Polycythemia Vera / Q000150:complications*; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D011379:Prognosis; D013920:Thrombocythemia, Essential / Q000150:complications*
IPSS; post-ET myelofibrosis; post-PV myelofibrosis; prognostic factors; survival